Skip to content
Sunday, June 26, 2022
Latest:
  • A potentially more effective treatment for HER2 mutant metastatic breast cancer
  • Finding pain relief in the kitchen
  • The 10th Annual Research Symposium of the Michael E. DeBakey Department of Surgery
  • All about autoimmune diseases
  • Welcome new School of Health Professions students!

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

cancer proteomics

From The Labs 

Proteomics analysis identifies potential drug targets for aggressive human cancers

March 4, 2021March 4, 2021agrressive cancer, cancer proteomics, cancer therapy, cancer transcriptomics, Research

Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: A selection of From the Labs Images of the Month on display in the A Hallway at Main Baylor.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951